A positive turn for CBD regulation: European Commission’s approval of Novel Food applications in 2022

The future looks bright for the CBD sector

A great number of CBD Novel Food applications have been pending for more than two years now (due to the pandemic), instigating a bit of fear, uncertainty and doubt to the CBD industry. Luckily, the recent developments at the EFSA, FSA and EC have turned this around and the future is once again looking bright for the exciting and ever-growing CBD sector.

Boris Baňas of CBDepot, one of the succesful applicants, expressed his positive outlook and stated to BusinessCann:

“This is a milestone for the industry. Finally, after more than a year the EC has formally recognised the decision of the ECJ in the KanaVape case.”

FSA adds EIHA applications for CBD isolate and CBD full spectrum to the on-hold list

Our trusted partners at the European Industrial Hemp Association have announced that EIHA Projects GmbH can move forward in the approval process (governed by the FSA) with their applications for isolate CBD and full spectrum CBD extract. These applications have now been placed on the ‘on-hold’ list, bringing them one step closer to complete validation.

Tony Reeves, member of the EIHA board, calls these events a blessing for many of its UK consortium participants. It seems that the advancements made by the EIHA have certainly helped to overcome one of the biggest regulation hurdles in the entire European CBD sector.

CBD Oil Europe provides excellent guidance for your CBD Novel Food approval

Let us help you bring your CBD products on the market legally. Our team of CBD experts will assist you in acquiring an EIHA sub-license, making your business a part of the EIHA Projects Novel Food consortium.

Sources:

https://businesscann.com

https://www.food.gov.uk

Share this article:

en_USEnglish

What are you looking for?